PMID: 9004982Sep 1, 1996Paper

Long-term stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence. II: Postnegative distinction and childhood predictors of adult outcome

The British Journal of Psychiatry : the Journal of Mental Science
M MaziadeM Martinez

Abstract

The aim of this study was to verify the presence and stability across life of the positive/negative distinction in early-onset schizophrenia (EO-SZ) through a longitudinal factor analysis of the schizophrenic dimensions, and to identify the factors predicting several indices of long-term outcome for EO-SZ. Forty children consecutively referred for DSM-III-R schizophrenia (SZ) in a specific catchment area comprised the sample. Across a 14.8-year follow-up, longitudinal factor analysis identified two separate factors corresponding to the positive and negative symptom dimensions. We also observed that: the GAS rated over the last three years of adult illness and the severity of negative symptoms during the stabilised interepisode intervals in adulthood were the indices of adult outcome that were most easily predicted; and the best childhood predictors of adult outcome were premorbid functioning and severity of positive and negative symptoms during acute episodes. The presence of premorbid non-psychotic behaviour disturbances (NPBD) and premorbid developmental problems was not related to severity of outcome, in contrast to the former variables.

References

Jan 1, 1979·Journal of Chronic Diseases·D L Sackett
Jan 1, 1978·Archives of General Psychiatry·R C BlandH Orn
Mar 1, 1978·Journal of Autism and Childhood Schizophrenia·C Eggers
Sep 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·V PeraltaM J Cuesta
Jan 1, 1992·Schizophrenia Bulletin·R M MurrayS W Lewis
Sep 1, 1992·Journal of the American Academy of Child and Adolescent Psychiatry·W H GreenM Bassiri
Dec 1, 1992·Journal of Autism and Developmental Disorders·J S Werry
Nov 1, 1992·Psychological Medicine·I BrockingtonH Y Meltzer
Jan 1, 1992·Journal of the American Academy of Child and Adolescent Psychiatry·J S Werry, J M McClellan
Mar 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·A Ambelas
Aug 1, 1992·The American Journal of Psychiatry·W G Iacono, M Beiser
Aug 11, 1992·Archives of General Psychiatry·J B WilliamsB Rounsaville
May 1, 1991·Acta Psychiatrica Scandinavica·H Jonsson, A K Nyman
Mar 1, 1991·The British Journal of Psychiatry : the Journal of Mental Science·S ArndtN C Andreasen
May 1, 1991·Journal of the American Academy of Child and Adolescent Psychiatry·J S WerryL Chard
Nov 1, 1990·Journal of Child Psychology and Psychiatry, and Allied Disciplines·R CaplanB Fish
May 1, 1989·Journal of the American Academy of Child and Adolescent Psychiatry·A T RussellC Sammons
Jun 1, 1989·Journal of Autism and Developmental Disorders·C Eggers
Jun 1, 1986·Acta Psychiatrica Scandinavica·M V Seeman
Jan 1, 1988·Schizophrenia Bulletin·T H McGlashanJ J Bartko
Jan 1, 1988·Schizophrenia Bulletin·W T Carpenter, B Kirkpatrick
Nov 1, 1988·Journal of Child Psychology and Psychiatry, and Allied Disciplines·J M WatkinsP E Tanguay
Feb 1, 1988·Psychological Medicine·F R VolkmarR Paul
Jul 1, 1988·The American Journal of Psychiatry·R M PostT W Uhde
Nov 1, 1986·Archives of General Psychiatry·M M WeissmanK K Kidd
Sep 1, 1987·Archives of General Psychiatry·H R BirdJ C Ribera
Aug 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·P F Liddle
Jan 1, 1986·The American Journal of Psychiatry·T H McGlashan
Jan 1, 1985·Schizophrenia Bulletin·R M BilderA K Pandurangi
Apr 1, 1971·The British Journal of Psychiatry : the Journal of Mental Science·I Kolvin
Apr 1, 1971·The British Journal of Psychiatry : the Journal of Mental Science·I KolvinA McNay
May 21, 1966·Nature·A R Kaplan
Oct 1, 1966·Mental Hygiene·D F Ricks, G Nameche
Dec 1, 1984·The British Journal of Psychiatry : the Journal of Mental Science·L Ciompi
Apr 1, 1984·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·R C Bland
May 1, 1980·The British Journal of Psychiatry : the Journal of Mental Science·L Ciompi
Jan 1, 1994·Schizophrenia Bulletin·E F TorreyK Sjostrom

❮ Previous
Next ❯

Citations

Nov 5, 1999·European Child & Adolescent Psychiatry·D BunkM Klapal
Sep 27, 2007·European Child & Adolescent Psychiatry·Nora S VyasSophia Frangou
Jul 27, 2001·Psychiatry Research·A SerrettiE Smeraldi
Sep 10, 1999·Schizophrenia Research·M NakayaK Ohmori
Feb 24, 2009·Journal of Child and Adolescent Psychopharmacology·Gabrielle A CarlsonMauricio Tohen
Nov 21, 2007·Schizophrenia Bulletin·Sophia FrangouApostolos Vourdas
Nov 24, 1999·Journal of the American Academy of Child and Adolescent Psychiatry·J McClellanA DuBose
Jul 11, 2002·Journal of the American Academy of Child and Adolescent Psychiatry·Jon McClellanKaren Jones
Oct 15, 2013·European Psychiatry : the Journal of the Association of European Psychiatrists·C SchneiderS Frangou
Jul 4, 2001·Journal of the American Academy of Child and Adolescent Psychiatry·UNKNOWN American Academy of Child and Adolescent Psychiatry
Oct 9, 2012·Child and Adolescent Psychiatric Clinics of North America·Ann E MaloneyJean A Frazier
Feb 2, 2011·Pediatric Clinics of North America·L Lee Carlisle, Jon McClellan
Aug 2, 2007·Journal of the American Academy of Child and Adolescent Psychiatry·Jean A FrazierLinmarie Sikich
Apr 25, 2007·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Vita DolzanKatja Breskvar
Sep 14, 2006·Acta Psychiatrica Scandinavica·H MengD Bürgin
Feb 13, 2010·Bipolar Disorders·Camilo J RuggeroEvelyn J Bromet
Sep 15, 2004·Neuroscience Letters·Alessandro SerrettiStephanie Ohlraun
Jul 22, 2005·Journal of the American Academy of Child and Adolescent Psychiatry·Trevor BallageerRaj Haricharan
Aug 27, 2013·Journal of the American Academy of Child and Adolescent Psychiatry·Jon McClellanUNKNOWN American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI)
May 7, 2002·American Journal of Medical Genetics·Alessandro SerrettiEnrico Smeraldi
Oct 12, 2016·Early Intervention in Psychiatry·Robin E GearingJames Mandiberg
Apr 17, 2008·Clinical Child Psychology and Psychiatry·Judith A ReavenRandal G Ross
Jan 16, 2019·Early Intervention in Psychiatry·Matteo TonnaUNKNOWN GET UP Group
Jan 1, 1997·The British Journal of Psychiatry : the Journal of Mental Science·M MaziadeC Mérette
Jul 31, 2010·Paediatric and Perinatal Epidemiology·Wieslaw A JedrychowskiJohn D Spengler
Feb 24, 2006·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Ashok K MallaRidha Joober
Jan 29, 2011·Early Intervention in Psychiatry·Nora S VyasBasant K Puri
Jan 1, 2015·NPJ Schizophrenia·Covadonga M Díaz-CanejaCelso Arango
Jan 23, 2002·Molecular Psychiatry·A SerrettiE Smeraldi
Nov 9, 2000·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·A D Baxter-Jones, P J Helms
Nov 18, 2017·Schizophrenia Research·Kirsten E S CraddockJudith L Rapoport

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved